NCT02220309View on ClinicalTrials.gov

Stanford RAD-AT Study (Research on Anxiety and Depression - Anhedonia Treatment)

Enrolling by invitationOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2024

Study Completion Date

April 30, 2025

Conditions
AnxietyDepression
Interventions
DRUG

Pramipexole Oral Tablet

Pramipexole is an oral Dopamine agonist.

Trial Locations (3)

94022

Gronowski Center-5150 El Camino Real, Los Altos

94304

VAPAHCS/Palo Alto MIRECC-3801 Miranda Avenue, Palo Alto

94305

Stanford University Department of Psychiatry, Stanford

All Listed Sponsors
lead

Stanford University

OTHER